Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
11.43
-0.04 (-0.35%)
Oct 1, 2026, 2:36 PM EDT - Market open
Climb Bio Employees
As of December 31, 2025, Climb Bio had 29 total employees, including 28 full-time and 1 part-time employees. The number of employees increased by 11 or 61.11% compared to the previous year.
Employees
29
Change (1Y)
11
Growth (1Y)
61.11%
Revenue / Employee
n/a
Profits / Employee
-$1,987,034
Market Cap
656.50M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 29 | 11 | 61.11% | 28 | 1 |
| Dec 31, 2024 | 18 | 7 | 63.64% | 17 | 1 |
| Dec 31, 2023 | 11 | -32 | -74.42% | 9 | 2 |
| Dec 31, 2022 | 43 | 12 | 38.71% | 30 | 13 |
| Sep 30, 2022 | 43 | 15 | 53.57% | 43 | 0 |
| Jun 30, 2022 | 41 | 16 | 64.00% | 41 | 0 |
| Mar 31, 2022 | 37 | 15 | 68.18% | 37 | 0 |
| Dec 31, 2021 | 31 | 9 | 40.91% | 19 | 12 |
| Sep 30, 2021 | 28 | - | - | 28 | 0 |
| Jun 30, 2021 | 25 | - | - | 25 | 0 |
| Mar 31, 2021 | 22 | - | - | 13 | 9 |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| CorMedix | 191 |
| DBV Technologies | 170 |
| Aura Biosciences | 113 |
| OmniAb | 89 |
| Silence Therapeutics | 88 |
| Crescent Biopharma | 69 |
| Zevra Therapeutics | 61 |
CLYM News
- 8 days ago - Climb Bio added to ‘Analysts Current Favorites’ at Raymond James - TheFly
- 15 days ago - Climb Bio Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 21 days ago - Climb Bio Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 23 days ago - Climb Bio price target raised to $25 from $18 at Oppenheimer - TheFly
- 23 days ago - Climb Bio price target raised to $30 from $24 at H.C. Wainwright - TheFly
- 26 days ago - Climb Bio management to meet with Piper Sandler - TheFly
- 27 days ago - Climb Bio price target raised to $30 from $26 at B. Riley - TheFly
- 27 days ago - Jade Biosciences price target raised to $48 from $25 at Clear Street - TheFly